Patents by Inventor Robert W. Payne

Robert W. Payne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10155039
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: December 18, 2018
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180311350
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: June 29, 2018
    Publication date: November 1, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180311352
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: June 29, 2018
    Publication date: November 1, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180311349
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: June 29, 2018
    Publication date: November 1, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180311351
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: June 29, 2018
    Publication date: November 1, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180140701
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: January 9, 2018
    Publication date: May 24, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180055929
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: October 5, 2017
    Publication date: March 1, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180055930
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: October 31, 2017
    Publication date: March 1, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180043018
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: October 5, 2017
    Publication date: February 15, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180043019
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: October 5, 2017
    Publication date: February 15, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180028654
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: October 10, 2017
    Publication date: February 1, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180028653
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: October 10, 2017
    Publication date: February 1, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180028657
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: October 11, 2017
    Publication date: February 1, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180028656
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: October 11, 2017
    Publication date: February 1, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180028655
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: October 11, 2017
    Publication date: February 1, 2018
    Applicant: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20180021433
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: August 15, 2017
    Publication date: January 25, 2018
    Inventors: Mark Manning, Robert W. Payne
  • Patent number: 9861695
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: January 9, 2018
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Patent number: 9808525
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: November 7, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Publication number: 20170312361
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: July 18, 2017
    Publication date: November 2, 2017
    Inventors: Mark Manning, Robert W. Payne
  • Patent number: 9789185
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: October 17, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne